Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone

Infection and Immunity

Volumn 65, Issue 6, 1997, Pages 2378-2381

  Van Der Poll, Tom ^a,b   Lowry, Stephen F ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; HYDROCORTISONE; INTERLEUKIN 8; LIPOPOLYSACCHARIDE;

ARTICLE; DRUG EFFECT; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATION; NORMAL HUMAN; PRIORITY JOURNAL; STRESS;

EID: 0030975951     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.6.2378-2381.1997     Document Type: Article

References (20)

1. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1045-1049.
2. Beutler, B., N. Krochin, I. W. Milsark, C. Luedke, and A. Cerami. 1986. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977-980.
3. Chollet-Martin, S., P. Montravers, C. Gibert, C. Elbim, J. M. Desmonts, J. Y. Fagon, and M. A. Gougerot-Pocidalo. 1993. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect. Immun. 61:4553-4559.
4. Colditz, I., R. Zwahlen, B. Dewald, and M. Baggiolini. 1989. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am. J. Pathol. 134:755-760.
5. DeForge, L. E., J. S. Kenney, M. L. Jones, J. S. Warren, and D. G. Remick. 1992. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J. Immunol. 148:2133-2141.
6. DeForge, L. E., D. E. Tracey, J. S. Kenney, and D. G. Remick. 1992. Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood. Am. J. Pathol. 140:1045-1050.
7. De Waal Malefyt, R., J. Ab rams, B. Bennett, C. Figdor, and J. E. de Vries. 1991. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
8. De Waal Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151:6370-6381.
9. Donnelly, S. C., R. M. Stricter, P. T. Reid, S. L. Kunkel, M. D. Burdick, I. Armstrong, A. Mackenzie, and C. Haslett. 1996. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann. Intern. Med. 125:191-196.
10. Hack, C. E., M. Hart, R. J. M. Strack van Schijndel, A. J. M. Eerenberg, J. H. Nuijens, L. G. Thijs, and L. A. Aarden. 1992. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect. Immun. 60:2835-2842.
11. Haskill, S., C. Johnson, D. Eierman, S. Becker, and K. Warren. 1988. Adherence induces selective mRNA expression of monocyte mediators and protooncogenes. J. Immunol. 140:1690-1694.
12. Hechtman, D. H., M. I. Cybulski, H. J. Fuchs, J. B. Baker, and M. A. Gimbrone, Jr. 1991. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J. Immunol. 147:883-892.
13. Mukaida, N., M. Shiroo, and K. Matsushima. 1989. Genomic structure of the human monocyte-derived neutrophilic chemotactic factor IL-8. J. Immunol. 143:1366-1371.
14. Severn, A., N. T. Rapson, C. A. Hunter, and F. Y. Liew. 1992. Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J. Immunol. 148:3441-3445.
15. Standiford, T. J., S. L. Kunkel, M. W. Rolfe, H. L. Evanoff, R. M. Allen, and R. M. Stricter. 1992. Regulation of human alveolar macrophage- and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone. Am. J. Respir. Cell Mol. Biol. 6:75-81.
16. Strieter, R. M., A. E. Koch, V. B. Antony, R. B. Fick, T. J. Standiford, and S. L. Kunkel. 1994. The immunoputhology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J. Lab. Clin. Med. 123:183-197.
17. Van der Poll, T., A. E. Barber, S. M. Coyle, and S. F. Lowry. 1996. Hypercortisolemia increases plasma inierleukin 10 concentrations during human endotoxemia. J. Clin. Endocrinol. Metab. 81:3604-3606.
18. Van der Poll, T., S. M. Coyle, K. Barbosa, C. C. Braxton, and S. F. Lowry. 1996. Epinephrine inhibits tumor necrosis factor α and potentiates interleukin 10 release during human endotoxemia. J. Clin. Invest. 97:713-719.
19. Van Zee, K. J., L. A. DeForge, E. Fischer, M. Marano, J. S. Kenney, D. G. Remick, S. F. Lowry, and L. L. Moldawer. 1991. IL-8 in septic shock, endotoxemia, and after 1L-1 administration. J. Immunol, 146:3478-3482.
20. Verghese, M. W., and R. Snyderman. 1983. Hormonal activation of adenylate cyclase in macrophage membranes is regulated by guanine nucleotides. J. Immunol. 130:869-873.